Clinical Trials Logo

Clinical Trial Summary

Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both urine output and how the body handles acid and base. This study will evaluate whether secretin levels are different in anorexic patients who urinate an excessive amount compared to those who urinate normal amounts. For this study, patients will have one extra blood draw before and after one meal during their hospitalization. The blood draw before the meal coincides with a standard of care blood draw. Also after the meal, subjects will be asked to provide one extra urine sample. Information from subject's medical records will also be used.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05235867
Study type Observational
Source University of California, Los Angeles
Contact Misciel Macaraig
Phone 310-825-0922
Email mbmacaraig@mednet.ucla.edu
Status Recruiting
Phase
Start date February 1, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06244576 - Emotional Dysregulation, Maladaptive Overcontrol in Anorexia - Effect of Radically Open Dialectical Behaviour Therapy N/A
Completed NCT03097874 - Adaptive Treatment for Adolescent Anorexia Nervosa N/A
Recruiting NCT05057000 - Effect of Aerobic Exercises and Nutrition In Adolescent Girls With Anorexia N/A
Recruiting NCT05674266 - New Treatment Perspectives in Adolescents With Anorexia Nervosa: the Efficacy of Non-invasive Brain-directed Treatment N/A
Recruiting NCT06097247 - Family Functioning and Adverse Side Effects of Family-based Therapy for Anorexia Nervosa
Recruiting NCT05418075 - Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa. N/A
Not yet recruiting NCT05249140 - Finding Treatments for Eating Disorders N/A
Terminated NCT05073679 - Oral Naltrexone In Pediatric Eating Disorders Phase 2/Phase 3